MichaelJBurkeMD

Forensic Psychiatry, Geriatric Psychiatry

Chief Medical Officer Larned State Hospital

Dr. Burke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1301 KS Hwy 264
Larned, KS 67550
Phone+1 620-285-4580

Fax+1 620-285-4381

Evaluation of Demonstrations to End Childhood Hunger - VA Start of enrollment: 2016 Sep 01
Completed
Not Applicable

PubMed

20 citations
Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.
Michael J. Burke, Mustafa M. Husain
The Journal of ECT. 2006-09-01
24 citations
Number of risk genotypes is a risk factor for major depressive disorder: a case control study
Holly A. Garriock, Pedro L. Delgado, Mitchel A. Kling, Linda L. Carpenter, Michael J. Burke
Behavioral and Brain Functions. 2006-07-05
171 citations
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.
David L. Dunner, A. John Rush, James M. Russell, Michael J. Burke, Stacy Woodard
The Journal of Clinical Psychiatry. 2006-05-15

Lectures

Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018